Ligand Pharmaceuticals Incorporated is in its Mars mahadasha (1 Aug 2022 to 1 Aug 2029), Mercury antardasha (31 Jan 2026 to 28 Jan 2027) and Jupiter pratyantar (14 Oct 2026 to 1 Dec 2026).
Next: pratyantar Saturn from 1 Dec 2026; antardasha Ketu from 28 Jan 2027; mahadasha Rahu from 1 Aug 2029.
| Planet | Sign | Degree | House | Nakshatra |
|---|---|---|---|---|
| Sun | Vrishchika (Scorpio) | 2°46′ | 12th | Vishakha 4 |
| Moon | Simha (Leo) | 17°32′ | 9th | Purva Phalguni 2 |
| Mars | Karka (Cancer) | 3°10′ | 8th | Punarvasu 4 |
| Mercury (R) | Vrishchika (Scorpio) | 10°25′ | 12th | Anuradha 3 |
| Jupiter | Kanya (Virgo) | 13°55′ | 10th | Hasta 2 |
| Venus | Dhanu (Sagittarius) | 12°21′ | 1st | Mula 4 |
| Saturn | Makara (Capricorn) | 19°01′ | 2nd | Shravana 3 |
| Rahu | Vrishchika (Scorpio) | 28°59′ | 12th | Jyeshtha 4 |
| Ketu | Vrishabha (Taurus) | 28°59′ | 6th | Mrigashira 2 |
Whole-sign houses counted from the lagna, True Chitra ayanamsa, Vimshottari dashas from the Moon's nakshatra. How the chart is cast.
The full chart adds the D1, D9 and D10 charts to explore, every antardasha and pratyantar, how LGND moved in each period against the S&P 500, transits, fundamentals and news.